EDITORIAL .......................................................................................................... 1 ÚVOD .................................................................................................................. 7
J. Blahoš
Aktivní společnost alergologie a klinické imunologie ČLS JEP ................................... 7

C. John
Klinická imunologie stále živá ................................................................................. 7

P. Barták
Jak běží čas ......................................................................................................... 9

1. ČÁST
ČSAKI – Česká společnost alergologie a klinické imunologie ................................... 13

ALERGOLOGIE A KLINICKÁ IMUNOLOGIE

Na Slupi a na Karlově náměstí .............................................................................. 22
Fakultní nemocnice Královské Vinohrady a 3. LF UK v Praze ................................... 23
Pediatrická alergologie: Sokolská – Motol – Bulovka ................................................ 26
Brno ................................................................................................................... 28
Olomouc ............................................................................................................. 31
Hradec Králové ..................................................................................................... 35
Ostravsko ............................................................................................................ 37
Plzeň .................................................................................................................. 39
České Budìjovice ................................................................................................. 40
Ústí nad Labem ................................................................................................... 41

REGIONY ........................................................................................................... 43

2. ČÁST
V. Špičák
Správná alergologická praxe v medicínì založené na dùkazech ................................ 52
Revize názvosloví v alergologii ............................................................................... 55
Standard testování kožními Prick testy a senzibilizace
ke vzdušným alergenùm v Evropě – projekt GA2LEN ................................................ 56

S. Bělohlávková
Standardizace provokaèních testù s potravinami
u pacientù s reakcemi okamžitého typu na potraviny ............................................... 57

V. Špičák
Standardy praktické alergenové imunoterapie ......................................................... 59

B. Novotná
Standard diagnostiky a péèe o pacienty s alergií na latex ....................................... 64

Z. Pelikán
Alergologie – QUO VADIS ? ................................................................................. 69

SLOVO ZÁVĚREM .............................................................................................. 71

CONTENTS

EDITORIAL .......................................................................................................... 1

J. Blahoš
The active Society of Allergology and Clinical Immunology
of the Czech Medical Association Jan Evangelista Purkyně .................................. 7

C. John
Clinical Immunology still living ............................................................................... 7

P. Barták
How the time is going ................................................................................................ 9

1st PART
CSAKI – Czech Society of Allergology and Clinical Immunology ............................. 13

ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Na Slupi and Charles Square .............................................................................. 22
Faculty Hospital Královské Vinohrady and 3th Medical
School Charles University Prague ........................................................................ 23
Paedidiatric allergology: Sokolská street – Motol – Bulovka .................................... 26
Brno .................................................................................................................. 28
Olomouc ............................................................................................................ 31
Hradec Králové ................................................................................................... 35
Ostrava .............................................................................................................. 37
Plzeň ................................................................................................................ 39
České Budějovice ................................................................................................ 40
Ústí nad Labem .................................................................................................. 41

REGIONS .......................................................................................................... 43

2nd PART
V. Špičák
Good practice in allergology with EBM .................................................................. 52
A revised nomenclature for allergy .......................................................................... 55
Standard SKIN PRICK TESTING and senzitisation to inhalant
allergens across Europe - a survey from the GA2LEN network ................................. 56

S. Bělohlávková
Standardization of food challenges in patients with immediate reactions
to foods - position paper from European Academy of Allergology
and Clinical Immunology ...................................................................................... 57

V. Špičák
Standards for practical allergen specific immunotherapy ........................................ 59

B. Novotná
Standard for diagnostics and treatment of the Latex Allergy ................................... 64

Z. Pelikán
Allergology – QUO VADIS? ................................................................................. 69

CONCLUSION .................................................................................................. 71

 

EDITORIAL ..................................................................................................................... 114
PŮVODNÍ PRÁCE

J. Libiger
Klasifikace v nesnázích ..................................................................................................... 116

R. Balon
Quo Vadis DSM? .............................................................................................................. 123

P. Grof
Jak diagnostikovat bipolární poruchu: problémy, které přinesly studie s potomky ........................................................................................................................... 127

M. Alda
Charakterizuje odpověď na profylaxi lithiem specifický typ bipolární
poruchy? ......................................................................................................................... 131

J. Volavka
Schizofrenie a násilí ......................................................................................................... 137

J. Horáček
Vliv polymorfizmu genu RGS4 (Regulator of G-protein signaling 4) na
regionální metabolizmus mozku (18FDG PET) a fenotypové proměnné
u schizofrenie ................................................................................................................... 141

CONTENTS

EDITORIAL ....................................................................................................................... 114

J. Libiger
Troubles of Psychiatric Classification .................................................................................. 116

J. Balon
Quo Vadis DSM? ............................................................................................................... 123

P. Grof
Diagnosing bipolar disorders: recent challenges from the studies
of offspring ........................................................................................................................ 127

M. Alda
Does response to prophylactic lithium characterize a distinct form of bipolar
disorder? ........................................................................................................................... 131

J. Volavka
Schizophrenia and violence .................................................................................................. 137

J. Horáček
The influence of polymorphism for gene RGS4 (Regulator of G-protein
signaling 4) on regional brain metabolism (18FDG PET) and phenotypic
variables in schizophrenia .................................................................................................... 141

EDITORIAL .......................................................................................................................... 1

PROGRAM .......................................................................................................................... 4

Středa 10. června ................................................................................................................. 4

Čtvrtek 11. června .................................................................................................................. 4

Pátek 12. června ................................................................................................................... 5

Sobota 13. června ................................................................................................................. 6

Postery ................................................................................................................................ 7

KRÁTKÁ SDĚLENÍ .............................................................................................................. 10

POSTERY ........................................................................................................................... 70

CONTENTS

EDITORIAL ........................................................................................................................... 1

PROGRAMME ...................................................................................................................... 4

Wednesday 10th June ............................................................................................................ 4

Thursday 11th June ................................................................................................................ 4

Friday 12th June .................................................................................................................... 5

Saturday 13th June ............................................................................................................... 6

Posters ................................................................................................................................ 7

SHORT COMMUNICATIONS ................................................................................................. 10

POSTERS ........................................................................................................................... 70

EDITORIAL ........................................................................................................................ 1 PROGRAM ........................................................................................................................ 4
PLENÁRNÍ PŘEDNÁŠKY .................................................................................................. 12
ODBORNÁ SYMPOZIA
ANTIPSYCHOTIKA
Představují antipsychotika a halucinogeny opačné strany téže mince? .................................. 14
Faktory ovlivňující volbu a efekt antipsychotik ....................................................................... 15
ANTIDEPRESIVA
Farmakoterapie deprese napříč diagnostickým spektrem ...................................................... 16
PERSONALIZOVANÁ FARMAKOTERAPIE I.
Psychofarmakogenetika ..................................................................................................... 18
Kontroverzní témata v hodnocení účinnosti psychofarmak ..................................................... 19
TERAPIE V NEUROPSYCHIATRII I.
Neuropsychiatrický profil a farmakoterapie onemocnění z okruhu
atypických parkinsonských syndromù ................................................................................. 20
Organické psychotické poruchy a možnosti jejich léèby ........................................................ 21
FARMAKOTERAPIE V PEDOPSYCHIATRII
Psychofarmaka v dětství a dospívání .................................................................................... 22
Aktuální otázky z pedopsychiatrické praxe ........................................................................... 23
TERAPIE V NEUROPSYCHIATRII II.
Farmakologické a invazivní terapeutické metody v neuropsychiatrii ......................................... 23
Neuronální mechanizmy „Systému odměny" ........................................................................ 24
FARMAKOTERAPIE V GERONTOPSYCHIATRII
Neurobiologie a psychofarmaka ve stáří ............................................................................... 26
Úzkostné poruchy ve vyšším vìku a jejich léčba .................................................................... 27
PERSONALIZOVANÁ FARMAKOTERAPIE II.
Predikce odpovědi na psychofarmaka .................................................................................. 28
Proč naši pacienti nechtějí brát léky a co s tím můžeme dělat ............................................... 29
SNÍDANĚ ČNPS
Cirkadiánní rytmicita: od vědy po praktické použití ................................................................ 30
Indikace psychofarmak podle pohlaví ................................................................................... 31
NOVÝ VÝZKUM
Nový výzkum I.: Preklinické studie ....................................................................................... 32
Nový výzkum II.: Od animálních studií k pacientovi.................................................................. 34
Nový výzkum III.: Klinické studie .......................................................................................... 35
WORKSHOPY
1. Psychogenní poruchy hybnosti ......................................................................................... 38
2. Umíme diagnostikovat a léčit autismus? ............................................................................ 38
3. Sedmero hlavních hříchů: Hněv .......................................................................................... 38
4. Jaká farmaka neužívat jako stabilizátory nálady? ................................................................ 39
5. Disociativní křeče ............................................................................................................ 40
6. Diferenciální diagnostika a farmakoterapie demencí ............................................................. 40
7. Optimalizace terapie afektivních a psychotických poruch ..................................................... 41
8. Psychózy 3. druhu: adekvátní diagnostika a léčba akutních psychotických poruch ................. 41
SETKÁNÍ S ODBORNÍKEM
Prof. Jan Volavka, MD, PhD .................................................................................................. 42
Prof. MUDr. Daniela Ježová, DrSc. ......................................................................................... 42
VÝVĚSKOVÁ SDĚLENÍ
Preklinický výzkum I. (stres, úzkost a neuroprotektivita) .......................................................... 43
Klinický výzkum I. (afektivní a úzkostné poruchy) .................................................................... 47
Preklinický výzkum II. (návykové látky a antipsychotika) .......................................................... 49
Klinický výzkum II. (psychózy a závislosti) ............................................................................. 52
Preklinický výzkum III. (kognitiva) ........................................................................................... 55
Klinický výzkum III. (problémové oblasti farmakoterapie) ........................................................... 58
FIREMNÍ SYMPOZIA ............................................................................................................ 61
REJSTŘÍK AUTORÙ ............................................................................................................. 62

CONTENTS

EDITORIAL ........................................................................................................................... 1 PROGRAMME ...................................................................................................................... 4
PLENARY LECTURES ......................................................................................................... 12
SCIENTIFIC SYMPOSIA
ANTIPSYCHOTICS
Are antipsychotics and hallucinogens opposite sides of the same coin? .................................... 14
Factors influencing choice and effect of antipsychotics ............................................................ 15
ANTIDEPRESSANTS
Pharmacotherapy of depression in different psychiatric conditions ............................................. 16
PERSONALIZED PHARMACOTHERAPY I.
Psychopharmacogenetics ...................................................................................................... 18
Controversies in evaluation of drug efficacy .............................................................................. 19
THERAPY IN NEUROPSYCHIATRY I.
Neuropsychiatric profile and pharmacotherapy of the atypical parkinsonian syndromes .......................................................................................................................... 20
Organic psychoses and possibilities of pharmacological treatment ........................................... 21
PHARMACOTHERAPY IN CHILD PSYCHIATRY
Child and adolescent psychopharmacology ............................................................................ 22
Current issues in child and adolescent psychiatric care ........................................................... 23
THERAPY IN NEUROPSYCHIATRY II.
Pharmacological and invasive methods in neuropsychiatry ....................................................... 23
Neuronal mechanisms of the „Reward system" ....................................................................... 24
PHARMACOTHERAPY IN GERIATRIC PSYCHIATRY
Neurobiology and psychotropics in the elderly ........................................................................ 26
Anxiety disorders in the elderly and their treatment ................................................................. 27
PERSONALIZED PHARMACOTHERAPY II.
Prediction of treatment response to psychotropic drugs ........................................................... 28
Why our patients do not want to take drugs and what we can do with it .................................... 29
ČNPS BREAKFAST SYMPOSIA
Circadian rhythms: From science to clinical application .......................................................... 30
Indication of psychotropic drugs based on gender .................................................................. 31
FREE COMMUNICATIONS – NEW RESEARCH
New Research I.: Preclinical studies ..................................................................................... 32
New Research II.: From animal studies to patients ................................................................. 34
New Research III.: Clinical studies ........................................................................................ 35
WORKSHOPS
1. Psychogenic movement disorders ..................................................................................... 38
2. Are we able to diagnose and to treat autism? ..................................................................... 38
3. Seven deadly sins – Anger ................................................................................................ 38
4. Which drugs should not be used as mood stabilizers? ......................................................... 39
5. Dissociative seizures ........................................................................................................ 40
6. Differential diagnosis and pharmacotherapy of dementia ...................................................... 40
7. Optimalization of treatment of affective and psychotic disorders ............................................ 41
8. Psychoses of the third kind: Diagnostics and treatment of acute psychotic disorders ............. 41
MEET THE EXPERT
Prof. Jan Volavka, MD, PhD. ................................................................................................. 42
Prof. MUDr. Daniela Ježová, DrSc. ......................................................................................... 42
POSTER SESSIONS
Preclinical Research I. (Stress, anxiety and neuroprotectivity) .................................................. 43
Clinical Research I. (Affective and anxiety disorders) ............................................................... 47
Prelinical Research II. (Addictive substances and antipsychotics) ............................................. 49
Clinical Research II. (Psychotic disorders and addiction) .......................................................... 52
Prelinical Research III. (Cognitive drugs) ................................................................................. 55
Clinical Research III. (Problems in pharmocotherapy) ............................................................... 58
INDUSTRY-SPONSORED SATELLITE SYMPOSIA ................................................................. 61
AUTHOR INDEX ................................................................................................................... 62

EDITORIAL .......................................................................................................... 1
SVĚTOVÝ DEN ASTMATU 2007 – DNY ASTMATU A ALERGIE
F. Salajka
Česká iniciativa pro astma o. p. s. 2007 ................................................................... 7
Kutná Hora – Pohár horských kol ........................................................................... 8
Pískání pro zdraví ...................................................................................................... 9
SVĚTOVÝ DEN ASTMATU – PRAHA 4. 5. 2007
V. Špičák, J. Kratěnová
Astma a alergie ve střední a východní Evropě ........................................................ 11
P. Pohunek
Co přinášejí nové doporučené postupy GINA dětským astmatikům ................... 15
Vr. Sedlák
Těžké a obtížně léčitelné asthma bronchiale .......................................................... 19
E. Králíková
Závislost na tabáku – souvislosti, souèasná léèba a situace v ÈR ......................... 22
VI. SETKÁNÍ LÉKAŘŮ ČR A SR V LITOMYŠLI – 11.–12. 5. 2007
J. Krejsek
Přirozená imunita jako fundament zánětové reakce.
Kam až sahají její kořeny? ........................................................................................ 26
I. Stříž
Imunita respiraèního ústrojí ..................................................................................... 28
M. Hrubiško
Ľahká a ťažká astma – jedna choroba alebo rôzne entity? .................................... 33
J. Vokurka
Kortikoidy u rinosinusitid ......................................................................................... 37
B. Novotná
Probiotika v primární prevenci alergií – pøehled studií .......................................... 43
XII. ČESKOLIPSKÝ DEN ASTMATU A ALERGIE – 17. 5. 2007
P. Macháček
Alergie na plísně a jejich diagnostika ...................................................................... 46
H. Vávrová
Alergeny jedu blanokřídlého hmyzu ........................................................................ 50
SVĚTOVÝ DEN ASTMATU V OLOMOUCI
J. Bystroň ..................................................................................................................... 52
INFORMACE ................................................................................................................ 53

CONTENTS

EDITORIAL .................................................................................................................. 1
WORLD ASTHMA DAY 2007 – DAYS OF ASTHMA AND ALLERGY
F. Salajka
Czech Initiative for Asthma 2007 .................................................................................. 7
Kutná Hora – Championship of mountain bikes ............................................................. 8
Whistling for Health .................................................................................................... 9
WORLD ASTHMA DAY – PRAG 4. 5. 2007
V. Špičák, J. Kratěnová
Asthma and Allergy in the Central and Eastern Europe .............................................. 11
P. Pohunek
How do children with asthma profit from the new GINA guidelines .................................. 15
Vr. Sedlák
Difficult to control bronchial asthma ........................................................................... 19
E. Králíková
Tobacco depedence – the context, current treatment
and situation in th CR ............................................................................................... 22
VIth MEETING OF THE CZECH and SLOVAK PHYSICIANS,
LITOMYŠL – 11.–12. 5. 2007
J. Krejsek
Innate immunity as a fundament of inflammation.
Where does its roots reach? ...................................................................................... 26
I. Stříž
Respiratory System Immunity ...................................................................................... 28
M. Hrubiško
Mild and severe asthma – one disease or different entities? ............................................ 33
J. Vokurka
Corticosteroids at rhinosinusitis ................................................................................... 37
B. Novotná
Probiotics in primary prevention of allergic diseases –
summary of the studies ............................................................................................. 43
ČESKÁ LÍPA – XIIth DAY OF ASTHMA AND ALLERGY – 17. 5. 2007
P. Macháček
Allergy on fungi and their diagnotics ........................................................................... 46
H. Vávrová
Hymenoptera venom allergens .................................................................................... 50
WORLD ASTHMA DAY OLOMOUC
J. Bystroň ................................................................................................................... 52
INFORMATIONS ......................................................................................................... 53

EDITORIAL ............................................................................................................................ 1
OBSAH ................................................................................................................................ 5
1. PLENÁRNÍ PŘEDNÁŠKY ................................................................................................... 9
2. IMUNOPATOGENEZE INFEKČNÍCH CHOROB
Přednášky ..........................................................................................................................10
Postery ............................................................................................................................. 12
3. MEZIOBOROVÝ POHLED NA RINITIDY
Pøednášky .......................................................................................................................... 14
Postery .............................................................................................................................. 18
4. MEZIOBOROVÝ POHLED NA ASTMA
Pøednášky .......................................................................................................................... 19
Postery ............................................................................................................................... 22
5. PŘIROZENÁ IMUNITA
Přednášky ........................................................................................................................ 28
Postery ............................................................................................................................. 29
6. SLIZNIČNÍ IMUNITA, STŘEVNÍ MIKROFLÓRA, PROBIOTIKA
Přednášky ......................................................................................................................... 33
Postery ............................................................................................................................... 34
7. INFEKCE, NÁDORY, IMUNITA – CO PŘINESE NEJLEPŠÍ EFEKT?
Přednášky ......................................................................................................................... 40
Postery ............................................................................................................................... 42
8. TRANSPLANTAČNÍ IMUNOLOGIE
Přednášky ........................................................................................................................ 43
Postery ............................................................................................................................. 46
9. NOVINKY V LABORATORNÍ SEKCI I., II.
Přednášky ......................................................................................................................... 47
Postery .............................................................................................................................. 53
10. VÝVOJOVÁ IMUNOLOGIE
Přednášky ......................................................................................................................... 55
Postery .............................................................................................................................. 56
11. IMUNOTOXIKOLOGIE
Přednášky ......................................................................................................................... 57
Postery .............................................................................................................................. 60
12. PREVENCE A TERAPIE ALERGICKÝCH CHOROB
Přednášky ........................................................................................................................ 62
Postery ............................................................................................................................. 65
13. PROJEVY A LÉÈBA KOŽNÍCH IMUNOPATOLOGICKÝCH NEMOCÍ
Přednášky .......................................................................................................................... 66
Postery .............................................................................................................................. 68
14. IMUNOLOGIE A ALERGOLOGIE V PEDIATRII
Přednášky ............................................................................................................................ 70
Postery .............................................................................................................................. 71
15. ANAFYLAXE A JEJÍ SPOUŠTÌÈE
Přednášky ...........................................................................................................................72
Postery ............................................................................................................................... 74
16. NEUROIMUNOLOGIE
Postery .............................................................................................................................. 75
17. CHOROBY Z AUTOIMUNITY
Přednášky ...........................................................................................................................76
Postery .............................................................................................................................. 79
18. IMUNODEFICIENCE – NUTNOST VČASNÉ DIAGNOSTIKY
Přednášky .......................................................................................................................... 83
Postery ................................................................................................................................ 85
19. PROJEVY IMUNOPATOLOGICKY PODMÍNĚNÝCH STAVŮ V ÚSTNÍ DUTINĚ
Přednášky ...........................................................................................................................88
Postery .............................................................................................................................. 89
20. ZÁNĚT A IMUNITA
Přednášky ........................................................................................................................... 90
Postery ................................................................................................................................ 92
21. REPRODUKČNÍ IMUNOLOGIE
Přednášky ............................................................................................................................ 94
Postery ............................................................................................................................... 96
22. FUNKČNÍ GENOMIKA – APLIKACE V MEDICÍNÌ
Přednášky .............................................................................................................................. 98
Postery .................................................................................................................................. 99
23. SIGNALIZAÈNÍ MECHANISMY IMUNORECEPTORÙ
Přednášky .............................................................................................................................. 99
Postery ................................................................................................................................. 100
24. LABORATORNÍ IMUNOLOGIE
Přednášky .............................................................................................................................101
Postery ................................................................................................................................. 103
25. MODERNÍ OŠETŘOVATELSTVÍ V ALERGOLOGII A KLINICKÉ IMUNOLOGII
Přednášky .............................................................................................................................106
Postery ................................................................................................................................ 110
26. VÝŽIVA A IMUNITA
Přednášky ............................................................................................................................. 110
27. FIREMNÍ SYMPOZIUM MSD .............................................................................................. 111
28. ZÁVĚREČNÁ PŘEDNÁŠKA ............................................................................................... 111
JMENNÝ REJSTŘÍK ................................................................................................................ 112–117

ABSTRACTS
ASTHMA, ALLERGY AND COPD 2006 – from the science to daily practice
GINA and the Patient
Suzanne S. Hurd ................................................................................................................ 6
Global Allergy and Asthma European Network (GA2LEN) and the Patient
P. Van Cauwenberge .......................................................................................................... 7
The patient Perspectives
Svein-Erik Myrseth ............................................................................................................ 8
How do we genuinely enhance doctor-patient partnership?
Martyn R Partridge............................................................................................................ 9
Primary Prevention of Allergy and Asthma
John Warner ....................................................................................................................... 10
Prevention of Allergy and Asthma – Dream or Reality?
Ulrich Wahn ....................................................................................................................... 11
From Asthma Mechanisms to Therapy in Practice
Peter Barnes ....................................................................................................................... 12
Asthma and COPD - one or two diseases?
Ronald Dahl ....................................................................................................................... 12
The burden of allergy: The patients' Voice
Erkka Valovirta .................................................................................................................. 13
Asthma, COPD and rhinitis in primary care
David Price ......................................................................................................................... 14
Pediatric asthma: How significant it is for the whole life?
Petr Pohunek ...................................................................................................................... 15
The Role of Genetics in the Evaluation of Asthma and its Treatment
Stephen T Holgate ............................................................................................................. 16
Allergy and asthma in future
Tari Haahtela ..................................................................................................................... 17
Message of nose to bronchi
Ester Seberová ................................................................................................................... 18
„Fighting for Breath" European patients' perspective on living
with severe asthma symptoms
Donna Covey ..................................................................................................................... 18
Refractory bronchial asthma – approach to our patients.
Vladimír Koblížek, Vratislav Sedlák, Zdeòka Paráková,
Bohuslav Král, František Salajka ..................................................................................... 19
Burden of chronic obstructive pulmonary disease (COPD) in Czech Republic
Jaromír Musil ..................................................................................................................... 19
European Pollen Information Service – benefit for patients
Siegfried Jaeger .................................................................................................................. 20
Smoking - cause or trigger
Viktor Kašák ...................................................................................................................... 21
Intervention in the indoor environment
Ariana Lajčíková ................................................................................................................ 21
We and Europe against food allergies
Simona Bìlohlávková ........................................................................................................ 22
CZECH INITIATIVE FOR ASTHMA ........................................................................... 23
ALLERGY AND ASTHMA IN THE CZECH REPUBLIC
Lékař a pacient. Partner a partner.
Physician and patient. Partner&Partner.
Viliam Meissner ................................................................................................................ 25
Kvalita života nemocných s tìžkým astmatem
Quality of life in patients with severe asthma
František Salajka .............................................................................................................. 29
Průduškové astma – od dětství do dospělosti
Bronchial asthma – From Childhood to Adulthood
Petr Pohunek ...................................................................................................................... 32
Poselství nosu průduškám
Message of nose to bronchi
Ester Seberová .................................................................................................................. 35
Pětileté sledování gravidních astmatiček
Asthma in Pregnancy- 5 years follow-up
Bronislava Novotná, Tomáš Pavlík ................................................................................. 39
Obtížně léčitelné astma (OLA) – pøístup k pacientovi s těžkým astmatem
Refractory bronchial asthma – approach to our patients
Vladimír Koblížek, Vratislav Sedlák, Zdeòka Paráková,
Bohuslav Král, František Salajka ................................................................................... 46
Aspirinem zlepšené astma (AZA) – vzácný fenotyp astmatu?
Aspirin-ameliorated asthma - a rare phenotype of asthma?
Krčmová Irena, Král Bohuslav, Paráková Zdena, Sedlák Vratislav,
Novotná Bronislava, Kašák Viktor, Halíková Jana, Chmelařová Soňa ........................ 49
Indukované sputum v èasné diagnostice astmatu
Induced sputum in early diagnostic of Asthma
Petr Panzner, Ivana Malkusová, Vladimír Hraško ......................................................... 52
Pohybová aktivita dìtských astmatikù
Physical activity in asthmatic children
Hana Janíčková, Zuzana Smrčková,
Jana Nosálová, Milena Dědičová .................................................................................... 55
Intervence ve vnitøním prostředí
Intervention in the Indoor Environment
Ariana Lajčíková ............................................................................................................... 59
Pylová informaèní služba
Pollen Information Service
Ondøej Rybníček ............................................................................................................... 63
Evropa a my proti potravinové alergii
We and Europe against Food Allergies
Simona Bělohlávková ....................................................................................................... 66
Farmakoekonomika astmatu v České republice
Pharmacoeconomics of asthma in Czech Republic
Viktor Kašák ..................................................................................................................... 67

EDITORIAL ........................................................................................................................1
ÚVODNÍ SLOVO ................................................................................................................2
PŮVODNÍ PRÁCE

Beáta Mikušová:
Neuropsychická záśaž, hodnotenie pracoviska a telesnej únavy u vozičkárov............................8

Lucie Kašparová, Jana Knotková:
Stanovení olova v krvi metodou atomové absorpèní spektrometrie s elektrotermickou atomizací
– mezilaboratorní kontrola kvality ..........................................................................................14

Ariana Lajčíková:
Elektroiontové mikroklima na klimatizovaných pracovištích .................................................... 18

PRACOVNĚ LÉKAŘSKÁ PÉČE O ZAMĚSTNANCE

Jaroslav Kresánek, Ferdinand Krutý, Štefánia Moricová:
Posudzovanie zdravotného stavu mladistvých k príprave na pracovné uplatnenie ...................... 22

PŘEHLEDNÉ ČLÁNKY

Josef Richter, Petr Šíma, Ivan Pfeifer, Bohumil Turek:
Nukleotidy a jejich význam ve zdraví a nemoci .................................................................... 26

AKTUÁLNÍ OTÁZKY ........................................................................................................ 28
PRÁVNÍ OKÉNKO ............................................................................................................31
SPOLEČNOST PRACOVNÍHO LÉKAŘSTVÍ

XXVI. Den neurotoxikologie a průmyslové neurologie ............................................................ 32
Vzdělávací akce Spoleènosti pracovního lékaøství v roce 2004 ............................................... 33

ZE SJEZDŮ A STUDIJNÍCH CEST

ZPRÁVY A INFORMACE

Rozloučili jsme se s prof. MUDr. Jiřím Vyskočilem, DrSc. .................................................... 38
Zajímavé adresy na internetu ............................................................................................. 38
90 let prof. MUDr. J. Müllera .............................................................................................. 39
Informace o nových metodických opatřeních vydaných MZ ČR .............................................. 40
Plán akcí ....................................................................................................................... 41
Veletrh A+A – Závěrečná zpráva ...................................................................................... 42

TEST ................................................................................................................................. 43
Z LITERATURY .............................................................................................................. 44
REJSTŘÍK 2004 ............................................................................................................... 49

CONTENTS

EDITORIAL ......................................................................................................................1
LEADING ARTICLE .......................................................................................................2
ORIGINAL PAPERS

Beáta Mikušová:
Neuropsychic Lpad, Evaluation of the Workplace and Physical Fatigue in Wheelchair Users .......8

Lucie Kašparová, Jana Knotková:
Determination of Lead in Blood by the Method of Atomic Absorption Spectrometry with
Electrochemical Atomization – Inter-laboratory Quality Control ................................................14

Ariana Lajčíková:
Electric Ion Microclimate in Air-conditioned Workplaces ...................................................... 18

OCCUPATIONAL MEDICAL CARE OF EMPLOYEES

Jaroslav Kresánek, Ferdinand Krutý, Štefánia Moricová:
Evaluation of General Health in Adolescents for Preparation to Assert Themselves at Work ............................................................................................................................ 22

REVIEWS

Josef Richter, Petr Šíma, Ivan Pfeifer, Bohumil Turek:
Nucleotides and their Role in Health and Disease ................................................................. 26

TOPICAL QUESTIONS ....................................................................................................... 28
LEGAL PANEL ...................................................................................................................31
SOCIETY FOR OCCUPATIONAL MEDICINE

XXVI. Day of Neurotoxicology and Industrial Neurology ............................................................ 32
Educational Program of Society for Occupational Medicine in 2004 .......................................... 33

FROM MEETINGS AND STUDY VISITS

COMMUNICATIONS AND INFORMATIONS

We Said Good Bye to Professor Jiří Vyskočil, M.D., D.Sc. .................................................... 38
Interesting Addresses on Internet .......................................................................................... 38
Ninety Years of Professor J. Müller, M.D., Coworker
and Cofounder of Radiation Hygiene in This Country ............................................................... 39
Information of New Methodic Measures Issued by Ministry
of Health, Czech Republic..................................................................................................... 40
Plan of Activity .................................................................................................................... 41
The Fair A+A – Final Report ................................................................................................. 42

TEST ................................................................................................................................. 43
LITERATURE .................................................................................................................. 44
INDEX 2004 ..................................................................................................................... 49

EDITORIAL ..................................................................................................................... 53

PŮVODNÍ PRÁCE
Zdenka Fenclová, Pavel Urban, Daniela Pelclová, Jindřiška Lebedová,
Edgar Lukáš, Tomáš Navrátil, Pavlína Klusáčková, Jiří Žák:
Profesionální onemocnìní hlášená v České republice v roce 2003 .......................................... 60
Pavel Hlaváč, Ivan Kučera:
Profesionální expozice pracovníků faktorům pracovního prostøedí ve vztahu k hlášeným
nemocím z povolání v roce 2003............................................................................................. 68
Vlastimil Kabíček, Martin Dušek:
Naše zkušenosti se zařazováním mládeže do práce ...............74

PŘEHLEDNÉ ČLÁNKY
Eva Králíková:
Pasivní kouření: klíčové téma pro lékaře i tabákový prùmysl.................................................. 79
Luděk Daneš:
Virus neštovic jako zbraň .................................................................................................. 83
AKTUÁLNÍ OTÁZKY .................................................................................................. 87
PRÁVNÍ OKÉNKO ....................................................................................................... 88
ZE SJEZDŮ A STUDIJNÍCH CEST
Kongres American College of Chest Physicians "CHEST 2003" Orlando, Florida ............ 89
Zajímavé adresy na internetu ................................................................................ 90

ZPRÁVY A INFORMACE
Zpráva o 43. výročním zasedání Německé společnosti pro pracovní lékařství a medicínu prostředí .. 91
Odvrácená tvář alkoholu .......................................................................................................... 92
TEST ..................................................................................................................................... 94
Z LITERATURY....................................................................................................................... 96

CONTENTS

EDITORIAL ........................................................................................................................... 53

ORIGINAL PAPERS
Zdenka Fenclová, Pavel Urban, Daniela Pelclová, Jindøiška Lebedová,
Edgar Lukáš, Tomáš Navrátil, Pavlína Klusáčková, Jiří Žák:
Occupational Diseases Acknowledged in Czech Republic in 2003 ........................................... 60

Pavel Hlaváč, Ivan Kučera:
Occupational Exposure of Workers to Factors of Working Environment in Relation
to Notified Occupational Diseases in the Year 2003 ............................................................ 68

Vlastimil Kabíček, Martin Dušek:
Our Experience in Placement of Youth to Jobs ......................................................................74

REVIEWS
Eva Králíková:
Passive Smoking: a Key Theme for Physicians and Tobacco Industry ..................................... 79

Luděk Daneš:
Variola Virus as Weapon .................................................................................................... 83

TOPICAL QUESTIONS ..................................................................................................... 87

LEGAL PANEL ................................................................................................................ 88

FROM MEETINGS AND STUDY VISITS
Congress of the American College of Chest Physicians "Chest 2003",
Orlando, Florida, 25-30 October 2003 ............................................................................... 89
Interesting addresses on Internet........................................................................................ 90

COMMUNICATIONS AND INFORMATIONS

Report on the 43th Anniversary of the Meeting of Germal
Society of Pacuclational Medicine and Environmental ............................................................ 91
Reverse Face of Alcohol ...................................................................................................... 92
TEST ................................................................................................................................. 94
LITERATURE.................................................................................................................. 96

EDITORIAL
PŮVODNÍ PRÁCE
Leona Hubačová: Dlhodobé nadmerné a jednostranné zaťaženie končatín
– hlásené choroby z povolania a rizikové práce v Slovenskej republike v rokoch 1996–2003

Zdenka Fenclová, Pavel Urban, Daniela Pelclová, Jindřiška Lebedová,
Edgar Lukáš: Analýza výskytu nemocí z přetěžování končetin
hlášených v České republice v letech 1996–2003

PRACOVNĚ LÉKAŘSKÁ PÉČE O ZAMĚSTNANCE
Květa Švábová: Pracovně lékařská problematika ve stavebnictví
Milan Tuček: Analýza pracovně lékařské péče v České republice

PŘEHLEDNÉ ČLÁNKY
Marta Hurbánková: Použitie bronchoalveolárnej laváže pri pľúcnych
ochoreniach vzniknutých po expozícii minerálnym prachom v experimente a u ľudí

Daniela Pelclová: Použití aktivního uhlí v klinické toxikologii

AKTUÁLNÍ OTÁZKY
Zeptali jsme se za vás paní MUDr. Hany Sovinové

SPOLEČNOST PRACOVNÍHO LÉKAŘSTVÍ
PRÁVNÍ OKÉNKO
ZE SJEZDŮ A STUDIJNÍCH CEST
XII. kongres České a Slovenské pneumologické a ftizeologické společnosti
11th International Workshop on QSAR in the Human
Health and Environmental Science (QSAR 2004)
Noční práce zkracuje život – lze proti tomu něco dělat?

ZPRÁVY
4th European Meeting of the WHO Collaborating Centers
in Occupational Health
Životné jubileum Prof. MUDr. Antonína Nauša, DrSc.
Plán akcí
TEST
REJSTŘÍKY

CONTENTS

EDITORIAL
ORIGINAL PAPERS
Leona Hubačová: Long-term excessive and unilateral load upon
extremities – notifi cation of occupational diseases and work
at risk in Slovak Republic in the years 1996-2003

Zdenka Fenclová, Pavel Urban, Daniela Pelclová, Jindřiška Lebedová,
Edgar Lukáš: Analysis of Incidence of Diseases from Excessive
Load upon Extremities as Notifi ed in the Czech Republic during 1996 – 2003

OCCUPATIONAL MEDICAL CARE OF EMPLOYEES
Květa Švábová: Occupational medical problems in construction industry

Milan Tuček: Analysis of occupational medical care in the Czech Republic

REVIEWS
Marta Hurbánková: Application of bronchiolar lavage in lung
diseases developed after exposure to mineral dusts in experiment and in humans
Daniela Pelclová: Application of Activated Charcoal in Clinical Toxicology

TOPICAL QUESTIONS
We asked this time Hana Sovinová, M.D. for you

SOCIETY OF OCCUPATIONAL MEDICINE
LEGAL PANEL
FROM MEETINGS AND STUDY VISITS
XII Congress of Czech and Slovak Pneumological and Phthisiological Society
Report of the 11th International Workshop on QSAR
in the Human Health and Environmental Science (QSAR 2004)
Night work shortens the life – can we do anything about it?
NEWS
Report on 4th European Meeting of the WHO Collaborating
Centres in Occupational Health
The Jubilee of Professor Nauš, M.D
Plan of Activity
TEST
Index